As of Thursday close, Oscar Health Inc.’s (NYSE:OSCR) stock was down -$0.17, moving down -2.87 percent to $5.75. The average number of shares traded per day over the past five days has been 1,974,340 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.49 fall in that time frame. In the last twenty days, the average volume was 1,721,770, while in the previous 50 days, it was 1,709,256.
Since last month, OSCR stock retreated -16.91%. Shares of the company fell to $5.72 on 09/21/23, the lowest level in the past month. A 52-week high of $9.89 was reached on 06/13/23 after having rallying from a 52-week low of $2.05. Since the beginning of this year, OSCR’s stock price has risen by 133.74% or $3.29, and marked a new high 34 times. However, the stock has declined by -41.86% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
OSCR stock investors should be aware that Oscar Health Inc. (OSCR) stock had its last reported insider trading activity 16 days ago on Sep 06. Blackley Richard Scott, the Chief Financial Officer of the company, disposed of 30,061 shares for $6.26 on Sep 06. It resulted in a $188,311 divestment by the insider. Quane Alessandrea C. sold 16,793 shares at an average price of $6.26 on Sep 06. The insider now owns 267,617 shares following the transaction. On Sep 05, Director Sankaran Sid sold 139,635 shares at $6.25 apiece. The transaction was valued at $872,719.
Valuation Metrics
The stock’s beta is 1.07. Besides these, the trailing price-to-sales (P/S) ratio of 0.26, the price-to-book (PB) ratio of 1.33, and the price-to-cash flow ratio of 8.43 may also be considered.
Financial Health
According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.31, and the total debt-to-equity ratio was 0.31. In the year ended June 29, operating margins totaled -9.00%. Based on annual data, OSCR earned -$610.08 million in gross profit and brought in $3.96 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -49.60%. Return on equity (ROE) for the past 12 months was -49.30%.
In Oscar Health Inc.’s quarter-end financial report for June 29, it reported total debt of $298.39 million. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. OSCR’s revenue rose 33.14% to $1.47 billion during the quarter, while net income inched up to $1.52 billion. While analysts expected Oscar Health Inc. to report -$0.23 quarterly earnings, the actual figure was -$0.07 per share, beating the consensus estimate by 69.60%. During the quarter, the company generated -$5.46 million in EBITDA. The value of shareholders’ equity is $221.91 million.
Technical Picture
This quick technical analysis looks at Oscar Health Inc.’s (OSCR) price momentum. With a historical volatility rate of 23.52%, the RSI 9-day stood at 25.19% on 21 September.
With respect to its five-day moving average, the current Oscar Health Inc. price is down by -7.85% percent or -$0.49. At present, OSCR shares trade -16.06% below its 20-day simple moving average and -14.56% percent below its 100-day simple moving average. However, the stock is currently trading approximately -24.04% below its SMA50 and +103.90% above its SMA200.
Stochastic coefficient K was 12.76% and Stochastic coefficient D was 15.99%, while ATR was 0.28. Given the Stochastic reading of 3.24% for the 14-day period, the RSI (14) reading has been calculated as 30.94%. As of today, the MACD Oscillator reading stands at -0.26, while the 14-day reading stands at -0.36.
With a median target price of $8.00, the current consensus forecast for the stock is $7.50 – $12.00. Based on these forecasts, analysts predict Oscar Health Inc. (OSCR) will achieve an average price target of $8.67.
